Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: BridgeBio Pharma Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Denali Therapeutics Inc. June 3, 202660.9%
-
Jazz Pharmaceuticals plc July 24, 202597.1%
-
BridgeBio Pharma Inc. June 21, 202496.8%
-
Denali Therapeutics Inc. June 1, 202383.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 31, 2026 | Jazz Pharmaceuticals plc | Shares withheld for tax | −14 | $244.06 | $3,417 |
| Aug 31, 2026 | Jazz Pharmaceuticals plc | Shares withheld for tax | −1,692 | $241.39 | $408,432 |
| Aug 5, 2026 | Jazz Pharmaceuticals plc | Grant or award | +1,605 | — | — |
| Jul 9, 2026 | BridgeBio Pharma Inc. | Option exercise | +19,000 | $8.45 | $160,550 |
| Jul 9, 2026 | BridgeBio Pharma Inc. | Option exercise | +112,422 | $29.00 | $3,260,238 |
| Jul 9, 2026 | BridgeBio Pharma Inc. | Option exercise | +17,167 | $16.75 | $287,547 |
| Jul 9, 2026 | BridgeBio Pharma Inc. | Open-market sale | −36,167 | $84.00 | $3,038,028 |
| Jul 9, 2026 | BridgeBio Pharma Inc. | Open-market sale | −112,422 | $90.00 | $10,117,980 |
| Jun 24, 2026 | BridgeBio Pharma Inc. | Option exercise | +20,000 | $8.45 | $169,000 |
| Jun 24, 2026 | BridgeBio Pharma Inc. | Option exercise | +17,167 | $16.75 | $287,547 |
| Jun 24, 2026 | BridgeBio Pharma Inc. | Open-market sale | −37,167 | $70.00 | $2,601,690 |
| Jun 23, 2026 | BridgeBio Pharma Inc. | Open-market sale | −2,196 | $68.57 | $150,580 |
| Jun 22, 2026 | BridgeBio Pharma Inc. | Grant or award | +3,990 | — | — |
| Jun 15, 2026 | BridgeBio Pharma Inc. | Option exercise | +65,921 | $8.45 | $557,032 |
| Jun 15, 2026 | BridgeBio Pharma Inc. | Option exercise | +17,167 | $16.75 | $287,547 |
Questions about Jennifer E. Cook
What boards is Jennifer E. Cook on?
Jennifer E. Cook sits on the boards of BridgeBio Pharma Inc., Denali Therapeutics Inc. and Jazz Pharmaceuticals plc.
How long has Jennifer E. Cook served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.